Invitation to individuals/networks to share
Dear…,
The National Cancer Institute’s (NCI) Center for Global Health (CGH) is initiating a survey to help us gain a better understanding of the current landscape of cancer therapeutic clinical trials in low- and middle-income countries (LMICs), as defined by the World Bank, and learn about clinicians’ thoughts and opinions regarding concrete steps that might be taken to advance clinical trials in LMICs.
We are seeking clinicians with experience participating as a member of a research team in at least one cancer therapeutic clinical trial with at least one recruitment site or facility in a LMIC to participate in a brief, 15-minute survey. Responses will help inform a strategic priority for CGH. The survey is anonymous and voluntary.
We invite you to share the survey [hyperlink] within your networks. The survey is available in Spanish, Portuguese, French, and Arabic. Please find attached a copy of this invitation in each language.
If you have any questions, visit [hyperlink-announcement webpage] or reach out to [email protected]. We are grateful for your support in this data collection and dissemination effort.
Individuals can access the survey with this link: [link]
Regards,
Ophira Ginsburg MSc MD (she/her)
Senior Advisor for Clinical Research
Center for Global Health
National Cancer Institute
Invitation to individuals to complete and share
Dear…,
The National Cancer Institute’s (NCI) Center for Global Health (CGH) is conducting a survey to gain a better understanding of the current landscape of cancer therapeutic clinical trials in low- and middle-income countries (LMICs), as defined by the World Bank, and learn about clinicians’ thoughts and opinions regarding concrete steps that might be taken to advance clinical trials in LMICs.
We invite you to take this brief, 15-minute survey [hyperlink]. As a clinician who may have experience participating as a member of a research team in at least one cancer therapeutic clinical trial with at least one recruitment site or facility in a LMIC, your input will help inform a strategic priority for CGH. The survey will be anonymous. There is no compensation for your participation.
Take the survey now. [hyperlink]
You are also encouraged to share the survey within your networks. The survey is available in Spanish, Portuguese, French, and Arabic. Please find attached a copy of this invitation in each language.
If you have any questions, visit [announcement webpage] or reach out to [email protected] . We are grateful for your support in this effort to learn more about cancer therapeutic clinical trials in LMICs.
Regards,
Ophira Ginsburg MSc MD (she/her)
Senior Advisor for Clinical Research
Center for Global Health
National Cancer Institute
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Eldridge, Linsey (NIH/NCI) [E] |
| File Modified | 0000-00-00 |
| File Created | 2023-09-26 |